Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
Advances in Experimental Medicine and Biology
|
January 1, 1993
Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis
G S Kerr, T A Fleisher, C W Hallahan, et al.
The Journal of Pediatrics
|
January 1, 1993
Wegener granulomatosis in children and adolescents: clinical presentation and outcome
M Rottem, A S Fauci, C W Hallahan, et al.
Annals of Internal Medicine
|
June 1, 1994
Takayasu arteritis
G S Kerr, C W Hallahan, J Giordano, et al.
AIDS (London, England)
|
August 16, 2001
Indinavir did not increase the short-term risk of adverse cardiovascular events relative to nucleoside reverse transcriptase inhibitor therapy in four phase III clinical trials
P M Coplan, A A Nikas, R Y Leavitt, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 1, 1995
Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis
F P Ognibene, J H Shelhamer, G S Hoffman, et al.
Open Forum Infectious Diseases
|
March 4, 2015
Safety Profile of the Merck Human Immunodeficiency Virus-1 Clade B gag DNA Plasmid Vaccine With and Without Adjuvants
Erin K Quirk, Elizabeth L Brown, Randi Y Leavitt, et al.
Annals of Internal Medicine
|
March 15, 1992
Wegener granulomatosis: an analysis of 158 patients
G S Hoffman, G S Kerr, R Y Leavitt, et al.
The Laryngoscope
|
December 1, 1992
The management of subglottic stenosis in patients with Wegener's granulomatosis
R S Lebovics, G S Hoffman, R Y Leavitt, et al.
AIDS (London, England)
|
April 28, 2011
Clinical efficacy of raltegravir against B and non-B subtype HIV-1 in phase III clinical studies
Jürgen K Rockstroh, Hedy Teppler, Jing Zhao, et al.
Open Forum Infectious Diseases
|
May 9, 2017
Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies
Kathleen Squires, Linda-Gail Bekker, Christine Katlama, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
Advances in Experimental Medicine and Biology
|
January 1, 1993
Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis
G S Kerr, T A Fleisher, C W Hallahan, et al.
The Journal of Pediatrics
|
January 1, 1993
Wegener granulomatosis in children and adolescents: clinical presentation and outcome
M Rottem, A S Fauci, C W Hallahan, et al.
Annals of Internal Medicine
|
June 1, 1994
Takayasu arteritis
G S Kerr, C W Hallahan, J Giordano, et al.
AIDS (London, England)
|
August 16, 2001
Indinavir did not increase the short-term risk of adverse cardiovascular events relative to nucleoside reverse transcriptase inhibitor therapy in four phase III clinical trials
P M Coplan, A A Nikas, R Y Leavitt, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 1, 1995
Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis
F P Ognibene, J H Shelhamer, G S Hoffman, et al.
Open Forum Infectious Diseases
|
March 4, 2015
Safety Profile of the Merck Human Immunodeficiency Virus-1 Clade B gag DNA Plasmid Vaccine With and Without Adjuvants
Erin K Quirk, Elizabeth L Brown, Randi Y Leavitt, et al.
Annals of Internal Medicine
|
March 15, 1992
Wegener granulomatosis: an analysis of 158 patients
G S Hoffman, G S Kerr, R Y Leavitt, et al.
The Laryngoscope
|
December 1, 1992
The management of subglottic stenosis in patients with Wegener's granulomatosis
R S Lebovics, G S Hoffman, R Y Leavitt, et al.
AIDS (London, England)
|
April 28, 2011
Clinical efficacy of raltegravir against B and non-B subtype HIV-1 in phase III clinical studies
Jürgen K Rockstroh, Hedy Teppler, Jing Zhao, et al.
Open Forum Infectious Diseases
|
May 9, 2017
Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies
Kathleen Squires, Linda-Gail Bekker, Christine Katlama, et al.
Page
of 6